Tough markets put Alcon’s leadership to the test
29/08/25 -"Despite being a dominant player in the ophthalmology space, Alcon has been reeling under the pressure of slower than expected market growth this year, competition and some impact from tariffs. In the ..."
Pages
50
Language
English
Published on
29/08/25
You may also be interested by these reports :
05/09/25
Bastide reported FY24/25 revenue in line with guidance and our forecast. The more technical business activities remain the primary driver of organic ...
05/09/25
Since we last pushed Philips’ (Buy; Netherlands) investment case in January 2024, its share price performance has been glaringly ahead of the MedTech ...
04/09/25
bioMerieux’s H1 profitability surpassed expectations. Topline growth was driven by robust performance across both segments. However, weakness in ...
29/08/25
Despite being a dominant player in the ophthalmology space, Alcon has been reeling under the pressure of slower than expected market growth this ...